Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
In your 20s, it's crucial to know what financial mistakes to avoid. Discover key insights to help you manage your money wisely.
26,712 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Ripple has joined Singapore’s MAS BLOOM sandbox to test automated RLUSD settlements on the XRP Ledger, amid participa...
As overseas conflict persists, American households face higher bills and tighter budgets. This report tracks where co...
Joby Aviation reports modest quarterly revenue gains and robust cash reserves while advancing certification and inter...
Bitcoin profit-taking is picking up as the bear-market rally continues. CryptoQuant reports rising on-chain profits a...
Microsoft rolled out an AI-powered Bing in limited beta, blending OpenAI technology with its own data. The move aims ...
Bitcoin surged toward a crucial resistance level as news spread that trump just flew china and a tech-heavy delegatio...
Inflation cools unevenly as growth slows, and the fed’s worst-case scenario quietly unfolds. Investors reassess risk ...
As AI demand accelerates, Nvidia stands out on a growth-adjusted valuation. Cramer argues the stock is cheaper than p...
Alphabet is quietly pivoting its AI strategy toward a new growth engine something. This shift could tilt Google Cloud...
Pi Network misses its upgrade deadline as the v23 rollout stalls. The PI token slides below key support, leaving inve...
A fast-moving convergence of quantum computing and robotics is reshaping portfolios. Three ETFs—QTUM, BOTZ, and ROBO—...